Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain

Neurobiology of Aging

Volumn 21, Issue 6, 2000, Pages 783-796

  Arendt, Thomas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYCLIN D1; CYCLIN DEPENDENT KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; PROTEIN P21; RAF PROTEIN;

ALZHEIMER DISEASE; BRAIN REGION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL STRUCTURE; CHOLINERGIC NERVE; DEREGULATION; FOREBRAIN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMAN; NERVE CELL PLASTICITY; NERVE DEGENERATION; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

EID: 0033635506     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00216-5     Document Type: Article

References (282)

1. Structural plasticity of synapses in Alzheimer's disease
2. MAP kinase does not inactivate, but rather prevents the cyclin degradation pathway from being turned on in Xenopus egg extracts
3. Neuronal dedifferentiation and degeneration in Alzheimer's disease
4. Alzheimer plaques and cortical cholinergic innervation
5. Loss of neurons in the Nucleus basalis of Meynert in Alzheimer's disease, Paralysis agitans and Korsakoff's disease
6. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease
7. Preserved neuronal plasticity in the reticular core during aging and in Alzheimer's disease
8. Is Alzheimer's disease associated with reexpression of a developmental protein pattern?
9. Perisomatic sprouts immunoreactive for nerve growth factor receptor and neurofibrillary degeneration affect different neuronal populations in the basal nucleus in patients with Alzheimer's disease
10. Maintenance of neuronal plasticity in the reticular core and changes in trophic activity in Alzheimer's disease
11. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease
12. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared to other subcortical areas
13. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurones that retain their capacity of plastic remodelling in the adult brain
14. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development
15. Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A
16. Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A
17. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's diesease
18. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease
19. Cortical load of PHF-tau in Alzheimer's disease is correlated to cholinergic dysfunction
20. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease
21. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. I. Dendritic organisation of the normal human basal forebrain
22. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease
23. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 Allele
24. Amyloid deposition in the nucleus basalis of Meynert complex; a topographic marker for degenerating cell clusters in Alzheimer's disease
25. Alzheimer's disease; increase in dendritic branching of reticular neurons in the basal nucleus-a sign of regeneration?
26. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease-a quantitative golgi investigation
27. Age-dependent deterioration of neuronal membranes and the pathogenesis of Alzheimer's disease; a hypothesis
28. Computer-assisted morphometry of synaptic plasticity during aging and dementia
29. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling neurons
30. Inhibitors of cyclin-dependent kinase and cancer
31. Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease
32. Long-lasting potentiation of synaptic transmission in the dentate area of the unanaesthetised rabbit following stimulation of the perforant path
33. Long-lasting potentiation of synaptic transmission in the dentate area of the unanaesthetised rabbit following stimulation of the perforant path
34. Structural characterization of the tumor suppressor p16, an ankyrin-like repeat protein
35. Mapping of the distribution of polysialylated neural cell adhesion molecule throughout the central nervous system of the adult rat; an immunohistochemistry study
36. Ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons
37. Ras p21 protein promotes survival and differentiation of human embryonic neural crest-derived cells
38. ERKs; a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
39. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control
40. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain-normal morphology and lamina-specific pathology in Alzheimer's disease
41. Neuropathological staging of Alzheimer related changes
42. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis
43. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
44. Synaptophysin immunoreactivity is depleted in cortical laminae with dense dystrophic neurites and neurofibrillary tangles
45. Dendritic growth in the aged human brain and failure of growth in senile dementia
46. Cortical plasticity; from synapses to maps
47. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
48. Brain interleukin-1 (IL-1)β in Alzheimer's disease and vascular dementia
49. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
50. Neuro-regeneration; plasticity for repair and adaptation
51. Nuclear localization and regulation of erk- and rsk-encoded protein kinases
52. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation
53. Mitogen-activated Swiss mouse 3T3 RSK kinases I and II are related to pp44 mpk from sea star oocytes and participate in the regulation of pp90rsk activity
54. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus
55. Trk receptor alterations in Alzheimer's disease
56. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia
57. Nerve growth factor and ras regulate β-amyloid precursor protein gene expression in PC12 cells
58. Molecular cascades in adaptive versus pathological plasticity
59. Axon sprouting in the rodent and Alzheimer's disease brain; a reactivation of developmental mechanisms?
60. Synapse replacement in the nervous system of adult vertebrates
61. Brain function, synapse renewal, and plasticity
62. NCAM is essential for axonal growth and fasciculation in the hippocampus
63. Detection of NGF-like activity in human brain tissue; increased levels in Alzheimer's disease
64. Sending signals from the synapse to the nucleus; possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth
65. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease
66. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways
67. Gases as biological messengers; nitric oxide and carbon monoxide in the brain
68. Structural correlates of cognition in dementia; quantification and assessment of synapse change
69. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade
70. Mitogen activated protein (Map) kinase transforms tau-protein into an Alzheimer-like state
71. Surface modulation in cell recognition and cell growth
72. Cell adhesion molecules in the regulation of animal form and tissue pattern
73. Morphoregulation
74. Neurogenesis in the adult human hippocampus
75. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type
76. The role of IL-6 in certain age-related diseases
77. Neuronal apoptosis is associated with a decrease in tau mRNA expression
78. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism
79. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease
80. Effects of apolipoprotein E genotype on blood lipid composition and membrane platelet fluidity in Alzheimer's disease
81. Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death
82. Growth of abnormal neurites in atypical Alzheimer's disease. A study with the Golgi method
83. Neuronal alterations in patients with dementia; a Golgi study on biopsy samples
84. Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission
85. Miliare Necrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmassige Veranderung der Hirnrinde bei seniler Demenz
86. Dendritic extent in human dentate gyrus granule cells in normal aging and senile dementia
87. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control
88. Analysis of cell cycle related gene expression in postmitotic neurons. Selective induction of cyclin D1 during programmed cell death
89. Neurofibrillary lesions in Alzheimer's disease are associated with 14-3-3 protein
90. Elevated expression of p21(ras) is an early event in Alzheimer's disease and precedes neurofibrillary degeneration
91. Induction of p21(ras) in Alzheimer pathology
92. Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1
93. Senile plaques as aberrant sprout-stimulating structures
94. Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease
95. Plasticity of hippocampal circuitry in Alzheimer's disease
96. Molecular markers of reactive plasticity
97. Increased expression of the embryonic form of a developmentally regulated mRNA in Alzheimer's disease
98. EM study of the numbers of cortical synapses in the brains of ageing people and people with Alzheimer-type dementia
99. Psychiatry and the new dynamics
100. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1-implication for Alzheimer's disease
101. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development
102. Tau proteins of Alzheimer paired helical filaments; abnormal phosphorylation of all six brain isoforms
103. Induction of basic fibroblast growth factor in Alzheimer's disease pathology
104. The contribution of altered synapses in the senile plaque; an electron microscopic study in Alzheimer's dementia
105. Phosphoprotein phosphatase-activities in Alzheimer's disease brain
106. Nitric oxide activity-dependent neuronel survival
107. Mechanisms and molecules that control growth cone guidance
108. MAP1B expression and microtubule stability in growing and regenerating axons
109. Studies on the comparative anatomy of the ganglion basale of Meynert
110. Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type
111. Secreted beta amyloid precursor protein stimulates mitogen activated protein kinase and enhances tau phosphorylation
112. Neuroscience, modularity and personality theory; conceptual foundations of a model of complex human functioning
113. Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation
114. Isolation and characterization of p19(INK4d), a p16-related inhibitor specific to CDK6 and CDK4
115. Synaptic loss in Alzheimer's disease and other dementias
116. Signaling through focal adhesion kinase
117. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
118. Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease
119. A computational model of the progression of Alzheimer's disease
120. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease
121. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease
122. Cell-death and the cell-cycle-a relationship between transformation and neurodegeneration
123. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide
124. Does neuronal modulation of p21 ras activity induce neurotrophic effects?
125. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism
126. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
127. Encephalization in hominids; evidence for the model of punctuationalism
128. Neuronal-based synaptic compensation; a computational study in Alzheimer's disease
129. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease
130. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
131. The central adaptation syndrome; psychosocial stress as a trigger for adaptive modifications of brain structure and brain function
132. Stress and the adaptive self-organization of neuronal connectivity during early childhood
133. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease
134. Induction of the cyclin-dependent kinase inhibitor p21 (Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells
135. Interaction foci, information synthesis, and mental activity
136. Modifiable neuronal connections; an overview for psychiatrists
137. Plastic neuronal changes in Alzheimer's disease associated with activation of astrocytes and enhanced neurotrophic activity
138. Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease
139. The reorganization of somatosensory cortex following peripheral nerve damage in adult and developing mammals
140. A cell cycle regulator potentially involved in genesis of many tumor types
141. Fetal-type phosphorylation of the tau in paired helical filaments
142. The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaques
143. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule
144. Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition
145. Neural cell adhesion molecule-stimualted neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway
146. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes
147. The neuritic dystrophy of Alzheimer's disease; degeneration or regeneration?
148. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease
149. Interaction of bride of sevenless membrane-bound ligand and the sevenless tyrosine-kinase receptor
150. Cyclin D1 is an essential mediator of apoptotic neuronal cell death
151. Nitric oxide regulates cell proloferation during Drosophila development
152. A molecular redox switch on p21 (ras). Structural basis for the nitric oxide-p21 (ras) interaction
153. Differential activation of mitogen-activated protein kinases by nitric oxide-related species
154. Nitric oxide-stimulated guanine nucleotide exchange on p21 ras
155. Synaptic pathology of Alzheimer's disease
156. Synaptic pathology in Alzheimer's disease; immunological data for markers of synaptic and large dense-core vesicles
157. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
158. Implication of brain Cdc2 and Map2 kinases in the phosphorylation of tau protein in Alzheimers-disease
159. Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation
160. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease; a quantitative study of visual and auditory cortices
161. cPLA2 is phosphorylated and activated by MAP kinase
162. Increased expression of cyclin D1 in the adult rat brain following kainic acid treatment
163. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level
164. Nitric oxide and Alzheimer's disease
165. Postnatal development of NADPH-diaphorase positive nerve cells in the visual cortex of the rat
166. Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21(ras) and p16(INK4a)
167. The plasticity-pathology continuum; defining a role for the LTP phenomenon
168. The microtubule-associated protein MAP1B is involved in local stabilization of turning growth cones
169. Microtubular reorganization and dendritic growth response in Alzheimer's disease
170. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease
171. Navigation-related structural change in the hippocampi of taxi drivers
172. Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosides
173. Glycogen-synthase kinase-3, and the Alzheimer-like state of microtubule-associated protein tau
174. From biophysics to models of network function
175. Mechanisms of synaptic dysfunction in Alzheimer's disease
176. Mechanisms of synaptic pathology in Alzheimer's disease
177. Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease
178. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease
179. Abnormal brain spectrin immunoreactivity in sprouting neurons in Alzheimer disease
180. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus
181. Increased immunoreactivity of brain spectrin in Alzheimer disease; a marker for synapse loss?
182. PDGF is associated with neuronal and glial alterations of Alzheimer's disease
183. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies
184. Patterns of aberrant sprouting in Alzheimer's disease
185. Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease
186. Synaptic and neuritic alterations during the progression of Alzheimer's disease
187. The synaptic organization of the neocortex in Alzheimer's disease
188. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system
189. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease
190. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease
191. Neuronal maturation and synaptogenesis in the rat ventrobasal complex; alignment with developmental changes in rate and severity of axon reaction
192. Signaling events regulating the neurodevelopmental triad. Glutamate and secreted forms of β-amyloid precursor protein as examples
193. Hippocampal plasticity in Alzheimer's disease; changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation
194. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway
195. Activation of a PP2A-like phosphatase and dephosphorylation of τ protein characterize onset of the execution phase of apoptosis
196. Effects of growth factors on intracellular pH regulation
197. A possible fetal antigen of Mr 70,000 in neurofibrillary tangles
198. Stimulation of immediate early gene expression in striatal neurons by nitric oxide
199. 14-3-3; modulators of signaling proteins?
200. Cellular pathology in Alzheimer's disease; implications for corticocortical disconnection and differential vulnerability
201. Structural and functional analysis of a mutant Ras protein that is insensitive to nitric oxide activation
202. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease
203. PSA-NCAM is required for activity-induced synaptic plasticity
204. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease
205. Cell cycle markers in the hippocampus in Alzheimer's disease
206. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions
207. The cell division cycle and the pathophysiology of Alzheimer's disease
208. Expression of a phosphorylated isoform of MAP1B is maintained in adult central nervous system areas that retain capacity for structural plasticity
209. pp125FAK in the focal adhesion
210. Src family protein tyrosine kinases; cooperating with growth factor and adhesion signaling pathways
211. Conversion of p35 to 25 deregulates Cdk5 activity and promotes neurodegeneration
212. Dendritic degeneration and regrowth in the cerebral cortex of patients with Alzheimer's disease
213. Plasticity in the organization of adult cerebral cortical maps; a computer simulation based on neuronal group selection
214. Mitogen-activated protein kinases; versatile transducers for cell signaling
215. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells
216. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells
217. Growth-regulated proteins and neuronal plasticity. A commentary
218. Increase of c-fos and ras oncoproteins in the denervated neuropil of the rat dentate gyrus
219. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells
220. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y
221. Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells
222. Neuritic plaques in senile dementia of Alzheimer type; a Golgi analysis in the hippocampal region
223. Phosphorylation of c-jun mediated by MAP kinases
224. Assessing some dynamic properties of the living nervous system
225. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease
226. Behaviorally based modeling and computational approaches to neuroscience
227. Axotomy-induced apoptotic cell death of neonatal rat facial motoneurons; time course analysis and relation to NADPH-diaphorase activity
228. Ras-signaling pathways; positive and negative regulation of tau expression in PC12 cells
229. Hyperactivation of signal transduction systems in Alzheimer's disease
230. Quantitative assessment of cortical synaptic density in Alzheimer's disease
231. Dendritic sprouting in Alzheimer's presenile dementia
232. NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells
233. Protein phosphorylation in neuronal plasticity and gene expression
234. Effect of cell spreading on cytoplasmic pH in normal and transformed fibroblasts
235. pH regulation in spread cells and round cells
236. Alzheimer's disease and Down syndrome; leukocyte membrane fluidity alterations
237. Distribution and possible roles of the highly polysialylated neural cell adhesion molecule (NCAM-H) in the developing and adult central nervous system
238. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
239. Signal transduction within the nucleus by mitogen-activated protein kinase
240. Inhibitors of mammalian G1 cyclin-dependent kinases
241. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1
242. Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoitic malignancies
243. The protein tyrosine kinase, fyn, in Alzheimer's disease pathology
244. Histologische Studien uber die senile Demenz
245. The brain as a self-organizing system
246. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease
247. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders
248. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle
249. Activation of Raf as a result of recruitment to the plasma membrane
250. Basic fibroblast growth factor in Alzheimer's disease
251. Epidermal growth factor receptor expression in demented and aged human brain
252. Identification and distribution of axonal dystrophic neurites in Alzheimer's disease
253. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein
254. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II)
255. Oncogenesis and altered differentiation induced by activated Ras in neuroblasts of transgenic mice
256. Physical basis of cognitive alterations in Alzheimer's disease; synapse loss is the major correlate of cognitive impairment
257. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type
258. Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation
259. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite
260. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
261. Aberrant expression of mitogenic Cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain
262. Mitogenic mechanisms in Alzheimer's disease?
263. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease
264. Observations on the evolution of the cholinergic system in the telencephalon of vertebrates
265. A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease
266. Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity
267. Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease
268. Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury
269. Prenatal development of NADPH-diaphorase reactive neurons in human frontal cortex
270. Brefeldin A-induced apoptosis is expressed in rat neurons with dephosphorylated tau protein
271. Nitric oxide synthase in motor neurons after axotomy
272. Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21 ras
273. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide
274. Platelet membrane fluidity individuals at risk for Alzheimer's disease; a comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy
275. Prospective study of risk factors for Alzheimer's disease; results at 7.5 years